Lenalidomide: a new treatment option for Castleman disease.

Details

Request a copyRequest a copy
Serval ID
serval:BIB_F55744EBCF57
Type
Article: article from journal or magazin.
Collection
Publications
Institution
Production externe
Title
Lenalidomide: a new treatment option for Castleman disease.
Journal
Leukemia & lymphoma
Author(s)
Szturz Petr, Adam Z., Chovancová J., Stehlíková O., Klabusay M., Rehák Z., Koukalová R., Krejčí M., Pour L., Zahradová L., Hájek R., Mayer J.
ISSN
1029-2403 (Electronic)
ISSN-L
1026-8022
Publication state
Published
Issued date
10/2012
Peer-reviewed
Oui
Volume
53
Number
10
Pages
2089-2091
Language
english
Notes
Publication types: Case Reports ; Letter ; Research Support, Non-U.S. Gov't
Publication Status: ppublish
Keywords
Antineoplastic Agents/administration & dosage, Antineoplastic Combined Chemotherapy Protocols/therapeutic use, Castleman Disease/diagnosis, Castleman Disease/drug therapy, Humans, Lenalidomide, Lymph Nodes/pathology, Male, Middle Aged, Multimodal Imaging, Positron-Emission Tomography, Thalidomide/analogs & derivatives, Thalidomide/therapeutic use, Tomography, X-Ray Computed, Treatment Outcome
DOI
10.3109/10428194.2011.621564
Pubmed
21902577
Web of science
000308213400024
Create date
07/01/2025 13:46
Last modification date
08/01/2025 7:04
Usage data